Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
November 2, 2011

India to extend pharmaceutical price control

India is to extend its price control of essential medicines from the current 34 to at least 400 drugs, accounting for approximately 60% of the domestic pharmaceutical market.

By Liam Stoker

India is to extend its price control of essential medicines from the current 34 to at least 400 drugs, accounting for approximately 60% of the domestic pharmaceutical market.

The National Pharmaceuticals Pricing Policy 2011, proposed by the Indian Government, seeks to cover all 348 medications named in 2005’s National List of Essential Medicines, as well as other medications added earlier this year.

The policy also promises to change the way prices are regulated, switching from a method based on market share to one based around the weighted average price of formulations belonging to the leading three brands.

Issued by the Department of Pharmaceuticals, the policy is also set to freeze prices on all drugs under price control for a further two years.

Related Companies

Content from our partners
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU